Phibro Animal Health | PAHC - 应收帐款人

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.29B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	应收帐款人	更改		日
Align Technology	USD 1.13B		23.36M	2026-03
ANI Pharmaceuticals	USD 255.43M		25.65M	2026-03
Assertio Holdings	USD 39.91M		2.7M	2024-06
Aurora Cannabis	CAD 48.26M		1.53M	2025-12
Bristol-Myers Squibb	USD 14.36B		164M	2026-03
Canopy Growth	CAD 140.42M		113.56M	2025-12
Corcept Therapeutics	USD 39.07M		20.71M	2026-03
Eli Lilly	USD 21.18B		1.02B	2026-03
Henry Schein	USD 1.72B		68M	2026-03
Idexx Laboratories	USD 697.21M		144.83M	2026-03
Knight Therapeutics	CAD 183M		7.46M	2025-12
Merck	USD 11.78B		345M	2025-12
Nektar Therapeutics	USD 1.78M		1.12M	2025-12
Pacira	USD 125.64M		1.57M	2026-03
Phibro Animal Health	USD 215.87M		2.02M	2025-12
Prestige Brands	USD 191.92M		1.46M	2026-03
Supernus Pharmaceuticals	USD 182.18M		5.62M	2026-03
Zoetis	USD 1.51B		84M	2026-03